Funding Daily Summary
Funding Daily Summary: What Happened on October 14, 2026
Soufflé Therapeutics raises $135 million for three drug candidates
Cori Clinical raised $4 million to expand its AI platform for clinical trial design.
-
P
Today in brief
Soufflé Therapeutics secured $135 million to move three candidates for FSHD, heart failure, and muscle and metabolic disorders toward clinical testing.1 Cori Clinical raised $4 million in seed funding to expand its AI platform for designing clinical trials.2
Soufflé raises $135 million to advance three candidates
Soufflé Therapeutics secured $135 million to advance three drug candidates toward clinical testing.1 The candidates target FSHD, heart failure, and muscle and metabolic disorders.1
Also worth knowing
-
P
Cori Clinical raised a $4 million seed round led by Breega, with Enzo, Heartfelt, Together Ventures, and Bynd also participating. The company plans to grow its team and expand the platform’s clinical and regulatory functions.2